Cargando…

3426 Increased Monounsaturated Fat Consumption is Associated with Improved Body Composition in Subjects with Obesity and Heart Failure with Preserved Ejection Fraction

OBJECTIVES/SPECIFIC AIMS: We hypothesized that increasing percent calories from MUFA (%MUFA) would be associated an increased FFM/FM index. METHODS/STUDY POPULATION: Nine consecutive HFpEF patients with obesity participated in a 12-week pilot feasibility trial of UFA supplementation (NCT03310099). S...

Descripción completa

Detalles Bibliográficos
Autores principales:	Billingsley, Hayley, Carbone, Salvatore, Rotelli, Brando, Kadariya, Dinesh, Canada, Justin M., Markley, Roshanak, Abbate, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2019
Materias:	Clinical Epidemiology/Clinical Trial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6799460/ http://dx.doi.org/10.1017/cts.2019.112

Ejemplares similares

2544: Dietary polyunsaturated fatty acid consumption is associated with improved body composition in nonalcoholic steatohepatitis patients
por: Billingsley, Hayley, et al.
Publicado: (2018)

Dietary Fat, Sugar Consumption, and Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction
por: Carbone, Salvatore, et al.
Publicado: (2017)

Edema Index Predicts Cardiorespiratory Fitness in Patients With Heart Failure With Reduced Ejection Fraction and Type 2 Diabetes Mellitus
por: Marawan, Amr, et al.
Publicado: (2021)

2390: Cardiac abnormalities drive exercise intolerance in patients with nonslcoholic fatty liver disease
por: Canada, Justin M., et al.
Publicado: (2018)

2363: Ventriculo-arterial coupling and left ventricular mechanical work in systolic and diastolic heart failure
por: Buckley, Leo, et al.
Publicado: (2018)

2438: Dose-dependent nature of cocaine infusions on cardiovascular hemodynamics
por: Carbone, Salvatore, et al.
Publicado: (2018)

Unsaturated Fatty Acids to Improve Cardiorespiratory Fitness in Patients With Obesity and HFpEF: The UFA-Preserved Pilot Study
por: Carbone, Salvatore, et al.
Publicado: (2019)

Low NT‐proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fraction
por: Buckley, Leo F., et al.
Publicado: (2018)

The effects of canagliflozin compared to sitagliptin on cardiorespiratory fitness in type 2 diabetes mellitus and heart failure with reduced ejection fraction: The CANA‐HF study
por: Carbone, Salvatore, et al.
Publicado: (2020)

Differential Response to Interleukin‐1 Blockade With Anakinra on Cardiorespiratory Fitness in Patients With Heart Failure With Preserved Ejection Fraction Stratified According to Left Ventricular Ejection Fraction
por: Golino, Michele, et al.
Publicado: (2023)

Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER‐like endpoint definitions
por: Anker, Stefan D., et al.
Publicado: (2022)

Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE‐HF trial roll‐in cohort
por: Fudim, Marat, et al.
Publicado: (2022)

Sarcopenic Obesity in Heart Failure With Preserved Ejection Fraction
por: Kirkman, Danielle L., et al.
Publicado: (2020)

Abnormal left ventricular subendocardial perfusion and diastolic function in women with obesity and heart failure and preserved ejection fraction
por: Markley, Roshanak, et al.
Publicado: (2023)

EAT Thickness as a Predominant Feature for Evaluating Arterial Stiffness in Patients with Heart Failure with Preserved Ejection Fraction
por: Liu, Zhiqiang, et al.
Publicado: (2022)

MicroRNA-126 Level Increases During Exercise Rehabilitation of Heart Failure with a Preserved Ejection Fraction
por: Jin, Dong, et al.
Publicado: (2021)

Biomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR–Preserved trial
por: Pocock, Stuart J., et al.
Publicado: (2022)

C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction
por: van Wezenbeek, Jessie, et al.
Publicado: (2018)

Concentration‐dependent clinical and prognostic importance of high‐sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR‐Reduced trial
por: Packer, Milton, et al.
Publicado: (2021)

Higher Intake of Polyunsaturated Fatty Acid and Monounsaturated Fatty Acid is Inversely Associated With AMD
por: Roh, Miin, et al.
Publicado: (2020)

Dapagliflozin and New York Heart Association functional class in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial
por: Ostrominski, John W., et al.
Publicado: (2022)

3193 Improving Individual Clinical Outcomes in a Sequential Multiple Assignment Randomized Trial (SMART)
por: Belli, Hayley M, et al.
Publicado: (2019)

Rhythm versus rate control for atrial fibrillation in heart failure with preserved ejection fraction
por: Al-Sadawi, Mohammed, et al.
Publicado: (2022)

Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial
por: Solomon, Scott D., et al.
Publicado: (2021)

EMPEROR-Preserved: SGLT2 inhibitors breakthrough in the management of heart failure with preserved ejection fraction
por: Wagdy, Kerolos, et al.
Publicado: (2021)

Outcomes of patients with heart failure with preserved ejection fraction undergoing catheter ablation of atrial fibrillation
por: Krishnamurthy, Amrita, et al.
Publicado: (2022)

Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON‐HF trial
por: Chatur, Safia, et al.
Publicado: (2022)

Red blood cell count and risk of adverse outcomes in patients with mildly reduced left ventricular ejection fraction
por: Liu, Zhican, et al.
Publicado: (2023)

Impaired myocardial relaxation with exercise determines peak aerobic exercise capacity in heart failure with preserved ejection fraction
por: Trankle, Cory, et al.
Publicado: (2017)

Breaking the Cycle of Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
por: Ţica, Otilia, et al.
Publicado: (2022)

3465 EXAMINING THE EFFECTS OF CHILDHOOD TRAUMA ON ADULT ALCOHOL CONSUMPTION: DOES RACE AND/OR SEX MATTER?
por: Byrd, Nia, et al.
Publicado: (2019)

Arrhythmic risk stratification in post-myocardial infarction patients with preserved ejection fraction: the PRESERVE EF study
por: Gatzoulis, Konstantinos A, et al.
Publicado: (2019)

4326 Effects of Single-dose Preoperative Pregabalin on Postoperative Pain and Opioid Consumption in Cleft Orthognathic Surgery
por: Said, Abdullah, et al.
Publicado: (2020)

Heart failure with preserved ejection fraction, atrial fibrillation, and the role of senile amyloidosis
por: van den Berg, Maarten P, et al.
Publicado: (2019)

Association between sub-clinical hypothyroidism and heart failure with preserved ejection fraction
por: Meng, Ying, et al.
Publicado: (2020)

Respiratory support in acute heart failure with preserved vs reduced ejection fraction
por: Metkus, Thomas S., et al.
Publicado: (2019)

Quantitative Proteomic Analysis of Diabetes Mellitus in Heart Failure With Preserved Ejection Fraction
por: Hanff, Thomas C., et al.
Publicado: (2021)

Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial
por: Böhm, Michael, et al.
Publicado: (2022)

Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial( )
por: Dachs, Theresa Marie, et al.
Publicado: (2022)

Epidemiology, Clinical Characteristics and Cause-specific Outcomes in Heart Failure with Preserved Ejection Fraction
por: Kapelios, Chris J, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0ddl4r6j1jcr79largc5svo9l1